Response to immunosuppressive therapy and an HLA-DRB1 allele in patients with aplastic anaemia: HLA-DRB1*1501 does not predict response to antithymocyte globulin

British Journal of Haematology

Volumn 92, Issue 1, 1996, Pages 155-158

  Nakao, Shinji ^a   Takami, Akiyoshi ^b   Sugimori, Naomi ^b   Ueda, Mikio ^b   Shiobara, Shintaro ^b   Matsuda, Tamotsu ^b   Mizoguchi, Hideaki ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b NONE

Author keywords

Antithymocyte globulin; Aplastic anaemia; Cyclosporine; HLA DR2; HLA DRB1

Indexed keywords

CYCLOSPORIN A; HLA DR ANTIGEN; HLA DR2 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; THYMOCYTE ANTIBODY;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030043165     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.293825.x     Document Type: Article

References (16)

1. Chapuis, B., Von Fliedner, V.E., Jeannet, M., Merica, H., Vuagnat, P., Gratwohl, A., Nissen, C. & Speck, B. (1986) Increased frequency of DR2 in patients with aplastic anaemia and increased DR sharing in their parents. British Journal of Haematology, 63, 51-57.
2. Frickhofen, N., Kaltwasser, J.P., Schrezenmeier, H., Raghavachar, A., Vogt, H.G., Herrmann, F., Freund, M., Meusers, P., Salama, A. & Heimpel, H. (1991) Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. New England Journal of Medicine, 324, 1297-1304.
3. Gluckman, E., Esperou, B.H., Baruchel, A., Boogaerts, M., Briere, J., Donadio, D., Leverger, G., Leporrier, M., Reiffers, J., Janvier, M., Michallet, M. & Stryckmans, P. (1992) Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. Blood, 79, 2540-2546.
4. Hashimato, M., Kinoshita, T., Yamasaki, M., Tanaka, H., Imanishi, T., Ihara, H., Ichikawa, Y. & Fukunishi, T. (1994) Gene frequencies and haplotype associations within the HLA region in 916 unrelated Japanese individuals. Tissue Antigens. 44, 166-173.
5. Imanishi, T., Akaza, T., Kimura, A., Tokunaga, K. & Gojobori, T. (1992) Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. HLA 1991 Proceedings of the 11th International Histocompatibility Workshop (ed. by K. Tsuji, M. Aizawa and T. Sasazuki), pp. 1065-1220. Oxford University Press.
6. Laver, J., Castro-Malaspina, H., Kernan, N., Levick, J., Evans, R., O'Reilly, R. & Moore, M. (1988) In-vitro interferon-gamma production by cultured T cells in severe aplastic anaemia: correlation with granulopoietic inhibition in patients who respond to anti-thymocyte globulin. British Journal of Haematology, 69, 545-550
7. Leonard, E.M., Raefsky, E., Griffith, P., Kimball, J., Nienhuis, A.W. & Young, N. (1989) Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia. British Journal of Haematology, 72, 278-284.
8. Maniatis, T., Fritson, E.F. & Sambrook, J. (1982) Molecular Cloning: a Laboratory Manual, p. 280. Cold Spring Harbor Laboratory Press, New York.
9. Nakao, S., Takamatsu, H., Chuhjo, T., Ueda, M., Shiobara, S., Matsuda T., Kaneshige, T. & Mizoguchi, H. (1994) Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia. Blood, 84, 4257-4261.
10. Nakao, S., Yamaguchi, M., Yasue, S., Shiobara, S., Saito, M. & Matsuda, T. (1992) HLA-DR2 predicts a favorable response to cyclosporine therapy in patients with bone marrow failure. American Journal of Hematology, 40, 239-240.
11. Nimer, S.D., Ireland, P., Meshkinpour, A. & Frane, M. (1994) An increased HLA DR2 frequency is seen in aplastic anemia patients. Blood, 84, 923-927.
12. Nishimura, Y., Thorsby, E., Ronningen, K.S., Nelson, L.J., Hansen, J.A., Bias, W.B., Fauchet, R., Dawkins, R.L., Tillikainen, A., Salvaneschi, L., Martinetti, M., Cuccia, M., Vaughan, R.W., Hall, M., Boehm, B.O., Juji, T., Ohno, S., Farid, N.R., Bodmer, J.G., Skamene, E., Marsh, D.G., Svejgaard, A., Thomsen, A.C. & Sasazuki, T. (1992) General organization and overview of the disease component. HLA 1991 Proceedings of the 11th International Histocompatibility Workshop (ed. by K. Tsuji, M. Aizawa and T. Sasazuki), pp. 693-700. Oxford University Press.
13. Ota, M., Seki, T., Fukushima, H., Tsuji, K. & Inoko, H. (1992) HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens. 39, 187-202.
14. Ragman, F.P., Ashby, D. & Davies, J.M. (1990) Does HLA-DR predict response to specific immunosuppressive therapy in aplastic anaemia? British Journal of Haematology, 74, 545.
15. Torok-Storb, B., Doney, K., Sale, G., Thomas, E.D. & Storb, R. (1985) Subsets of patients with aplastic anemia identilied by flow microfluorometry. New England Journal of Medicine, 312, 1015-1022.
16. Young, N.S., Griffith, P., Brittain, E., Elfenbein, G., Gardner, F., Huang, A., Harmon, D., Hewlett, J., Fay, J., Mangan, K., Morrison, F., Sensenbrenner, L., Shadduck, R., Wang, W., Zaroulis, C. & Zuckerman, K. (1988) A multicenter trial of antithymocyte globulin in aplastic anemia and related disease. Blood, 72, 1861-1869.